THE WOODLANDS, Texas, Aug. 20, 2009 (GLOBE NEWSWIRE) -- Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced today that the company made significant advances in the technology for their BC-SeraPro serum protein based blood test for diagnosis of early stage breast cancer, as disclosed in recent filings of three pending US utility patent applications.
